Busulfan, cyclophosphamide, and etoposid
✍
Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 77 KB
👁 2 views
## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of high‐dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel